Breaking News
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making
October 22, 2018 - Radiotherapy can prolong survival in prostate cancer
October 22, 2018 - A genetic mutation involved in relapse
October 21, 2018 - Report reveals growing impact of cannabis on young people
October 21, 2018 - NSF awards $5 million grant to help scientists magnify societal impact of research
October 21, 2018 - Fertility Rates Down for Each Urbanization Level 2007 to 2017
October 21, 2018 - Genetically engineered 3-D human muscle transplant in a murine model
October 21, 2018 - Moms’ tight work schedules may affect their children’s sleep
October 21, 2018 - AHA: No Direct Link Between Preeclampsia and Cognitive Impairment, Study Finds
October 21, 2018 - Weight loss success linked with active self-control regions of the brain
October 21, 2018 - Scripps researchers successfully test potential new smoking-cessation treatment in rodents
October 21, 2018 - More accurate and less stressful way to measure a baby’s heartbeat
October 21, 2018 - Researchers show better cardiorespiratory fitness leads to longer life
October 21, 2018 - Healthy candies for diabetic patients
October 21, 2018 - Environment impact of microplastics remains unclear
October 21, 2018 - Antibiotics for appendicitis? Surgery often not needed
October 21, 2018 - AHA and AMA recognize more than 800 medical practices, health systems for blood pressure control
October 21, 2018 - Scientists obtain clearest ever image of Ebola virus protein
October 21, 2018 - Study reveals connection between two proteins known to be hyperactive in cancer
October 21, 2018 - Gabapentin Beats Pregabalin for Chronic Sciatica
October 21, 2018 - Cosmetic surgeons offering incomplete information for breast augmentation customers
October 21, 2018 - Chronic sleep disruption in early adult life accelerates AD-related tau pathology
October 21, 2018 - Take 10 for Mindfulness – Drugs.com MedNews
October 21, 2018 - Length of breathing disruption in OSA may be better predictor of mortality risk
October 21, 2018 - ApoE4 gene linked with chronic inflammation increases risk for Alzheimer’s disease
October 21, 2018 - Mother-daughter conflict associated with suicide risk in abused adolescent girls
October 21, 2018 - Scientists molding bacteria into unnatural shapes
October 21, 2018 - High diet quality associated with lower risk of death in colorectal cancer patients
October 21, 2018 - Discharged mental health patients ‘at greater risk of dying’
October 21, 2018 - Research provides insight into neurobiology of aggression and bullying
Kidney Dysfunction Frequent in RA

Kidney Dysfunction Frequent in RA

image_pdfDownload PDFimage_print

Action Points

  • Renal dysfunction is common among patients with rheumatoid arthritis, particularly among older patients, women, and those with hypertension.
  • Hypertension and diabetes were observed more often among those with renal dysfunction, but obesity was less common.

Renal dysfunction is common among patients with rheumatoid arthritis (RA), particularly among older patients, women, and those with hypertension, Japanese researchers reported.

Using absolute estimated glomerular filtration rates (eGFR), 33.8% of patients had renal dysfunction, according to Shunsuke Mori, MD, of Kumamoto Saishunsou National Hospital in Kohshi, and colleagues.

And in a multivariate analysis, the odds ratios for renal dysfunction were 7.24 (95% CI 5.71-9.18, P<0.001) for age over 65, 3.12 for female gender (95% CI 2.29-4.24, P<0.001), and 2.22 for hypertension (95% CI 1.76-2.80, P<0.001), the researchers reported in Clinical Rheumatology.

The researchers stressed, however, that these analyses relied on the absolute eGFR, rather than a body surface area-indexed eGFR. According to the absolute eGFR, renal dysfunction was defined as less than 60 mL/min, while the body surface area-adjusted eGFR was less than 60 mL/min/1.732. The researchers pointed out that the body surface area-adjusted eGFR can be misleading in patients who are either obese or very lean, and in this study the mean body surface area was 1.52 m2 rather than 1.73 m2.

Earlier studies describing biopsy and clinical renal findings in patients with RA suggested that the dominant manifestations were secondary amyloidosis, membranous nephropathy, mesangial glomerulonephritis, and vasculitis. However, those studies were based on patients being treated with older antirheumatic drugs such as gold and penicillamine, which have been associated with nephrotoxicity, and secondary amyloidosis is now uncommon because of improved RA treatment.

Nonetheless, renal involvement in RA may be increasing despite modern treatments, and may be contributing to RA patients’ persistently increased mortality.

To examine current patterns of renal dysfunction in RA, Mori’s group conducted a cross-sectional study, recruiting 1,908 patients from three outpatient centers in Japan during 2014 and 2015. For each patient, they collected demographic characteristics, RA disease features such as duration, disease activity, and seropositivity, medication use, and traditional cardiovascular risk factors such as hypertension and diabetes.

Using the absolute eGFR cutoff, characteristics of patients with renal dysfunction included greater age, with more than half of individuals older than 70 being affected, and female sex.

When body surface area-indexed eGFR was used, the prevalence of renal dysfunction was much lower than with the absolute eGFR, at 18.6%, which is comparable with the frequency in the overall Japanese population.

With the absolute eGFR calculation, patients with renal dysfunction were older than those without dysfunction (72 versus 58.8 years, P<0.001), had longer duration of RA (12 versus 10.1 years, P<0.001), and more often had high disability classification (52.7 versus 45.2, P=0.002). They also had higher scores on the Health Assessment Questionnaire (HAQ; 0.56 versus 0.35, P<0.001).

Hypertension and diabetes were observed more often among those with renal dysfunction, but obesity was less common. Women more often had renal dysfunction.

With the body surface area-indexed eGFR, renal dysfunction was again associated with older age (73.1 versus 61, P<0.001), though not with gender. Disease duration, higher HAQ scores, hypertension, and diabetes also were associated with renal dysfunction.

A total of 51.6% of patients were receiving methotrexate, and 33.6% were being treated with biologics. Methotrexate was used less often among patients with renal dysfunction calculated according to both absolute eGFR (43.6% versus 55.7%, P<0.001) and body surface area-indexed eGFR (39.4% versus 54.3%, P<0.001). Biologics were more often used among patients with renal dysfunction according to the absolute eGFR, while steroids were more often given to those with renal dysfunction according to the body surface area-indexed eGFR.

On the multivariate analyses, obesity was negatively associated with renal dysfunction according to the absolute eGFR.

With the body surface area-indexed eGFR, independent associations were seen for age over 65 (OR 5.19, 95% CI 3.83-7.05, P<0.001) and hypertension (OR 3.05, 95% CI 2.37-3.96, P<0.001). Statistically significant associations were not seen according to this calculation for female gender.

“Considering that RA patients, especially elderly individuals, are likely to present a smaller body size than 1.73 m2, it would be better to consider using absolute eGFR instead of body surface area-indexed eGFR in studies for RA patients,” the researchers argued.

Regular monitoring of renal function is advisable in patients with RA, so that early intervention can help prevent kidney complications, they concluded.

A limitation of the study was its cross-sectional design, so causality cannot be inferred.

The study was supported by the National Hospital Organization of Japan.

Mori and co-authors disclosed no relevant relationships with industry.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2017-12-12T00:00:00-0500

last updated

Tagged with:

About author

Related Articles